![[HTML version]](/e/graphics/htmlborder.gif)
![[PDF version]](/e/graphics/pdfborder.gif)
![[CIF]](/e/graphics/cifborder.gif)
![[3d view]](/e/graphics/3dviewborder.gif)
![[Structure Factors]](/e/graphics/structurefactorsborder.gif)
![[Supplementary Material]](/e/graphics/supplementarymaterialsborder.gif)
![[CIF check Report]](/e/graphics/checkcifborder.gif)
![[Open access]](/e/graphics/free.gif)
![[Contents scheme]](ci2644contents.gif)
Acta Cryst. (2008). E64, m1168-m1169 [ doi:10.1107/S1600536808025713 ]
2O4,O5)(4-oxido-2-oxo-1,2-dihydropyrimidin-3-ium-5-carboxylato-
2O4,O5)bis(1,10-phenanthroline-
2N,N')gadolinium(III) dihydrateAbstract: The title compound, [Gd(C5H2N2O4)(C5H3N2O4)(C12H8N2)2]·2H2O, was obtained from a solvothermal reaction of 2,4-dihydroxypyrimidine-5-carboxylic acid (H3iso), GdCl3·6H2O and 1,10-phenanthroline (phen). The GdIII ion is located on a twofold rotation axis and is coordinated by four N atoms from two chelating phen ligands and four O atoms (5-carboxylate and 4-oxido O atoms) from H2iso- and Hiso2- ligands. The molecules are linked into a three-dimensional network by N-H
O, N-H
N and O-H
O hydrogen bonds. The H atom involved in an N-H
N hydrogen bond is disordered around a twofold rotation axis with half occupancy.
Online 16 August 2008
Copyright © International Union of Crystallography
IUCr Webmaster